Core Laboratories (CLB) Lowers Q4 EPS Guidance, Q1 Guidance Misses, Cuts Dividend

Go back to Core Laboratories (CLB) Lowers Q4 EPS Guidance, Q1 Guidance Misses, Cuts Dividend

Core Laboratories (CLB) PT Lowered to $39 at Cowen

December 31, 2019 6:05 AM EST

Cowen analyst Marc Bianchi lowered the price target on Core Laboratories (NYSE: CLB) to $39.00 (from $42.00) while maintaining a Market Perform rating.

The analyst comments "4Q EPS pre-released below our consensus-low estimate. Initial 1Q revs/EPS guide implies a sequential improvement in what... More